Keyphrases
Mechanism of Atherosclerosis
100%
HIV+
100%
HIV Infection
100%
HIV Patients
57%
Women's Interagency HIV Study
42%
Intima-media Thickness
28%
Inflammation Markers
28%
Highly Active Antiretroviral Therapy (HAART)
28%
Antiviral Drugs
28%
Protease Inhibitors
28%
Lipodystrophy Syndrome
14%
Cardiovascular Events
14%
Negative Control
14%
CD4 Count
14%
Metabolic Abnormalities
14%
Vascular Effects
14%
HIV-negative
14%
Intercellular Adhesion molecule-1 (ICAM-1)
14%
Hypertriglyceridemia
14%
Carotid Ultrasound
14%
People Living with HIV (PLHIV)
14%
Hispanic
14%
Major Questions
14%
Subclinical Atherosclerosis
14%
Diabetes
14%
B-mode Image
14%
African American
14%
Imaging Methods
14%
Accelerated Atherosclerosis
14%
Change of Measure
14%
HIV Viral Load
14%
Lipodystrophy
14%
Carotid Artery Intima-media Thickness
14%
Endothelial Adhesion Molecules
14%
Metabolic Effects
14%
HIV-associated Lipodystrophy Syndrome
14%
Antiretroviral
14%
Causal Mechanisms
14%
High CRP
14%
Premature Atherosclerosis
14%
Imaging Facility
14%
Clinical Significance
14%
E-selectin
14%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Mechanism of Atherosclerosis
100%
Atherosclerosis
72%
Human Immunodeficiency Virus Infection
63%
Intima-Media Thickness
27%
Highly Active Antiretroviral Therapy
18%
Proteinase Inhibitor
18%
Intercellular Adhesion Molecule 1
9%
Cardiovascular System
9%
Mediator
9%
Lipodystrophy
9%
Prematurity
9%
Cohort Analysis
9%
Hypertriglyceridemia
9%
Artery Intima
9%
Cell Adhesion Proteins
9%
Atherogenesis
9%
Ultrasonography
9%
HIV-associated Lipodystrophy
9%
Diabetes
9%
Endothelial Leukocyte Adhesion Molecule 1
9%
Carotid Artery
9%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
100%
HIV
100%
Human Immunodeficiency Virus Infection
63%
Inflammation
18%
Proteinase Inhibitor
18%
Hypertriglyceridemia
9%
HIV Associated Lipodystrophy
9%
Lipodystrophy
9%
Atherogenesis
9%
E-Selectin
9%
Intercellular Adhesion Molecule 1
9%
Syndrome
9%
Cohort Study
9%
Cell Adhesion Proteins
9%
Prematurity
9%